medigraphic.com

2022, Number 2

<< Back Next >>

Rev Mex Anest 2022; 45 (2)

Treatment of acute pain from traumatic injury in patients with addictions

Vélez-Tovar LF, Cruz-Nocelo EJ, Serratos-Vázquez MC, Zúñiga-Carmona VH

Language: Spanish
References: 17
Page: 107-113
PDF size: 280.40 Kb.


ABSTRACT

Introduction: Current guidelines for pain management in addiction patients do not address acute pain care. Objective: To describe the analgesic treatment schemes and the average dose of opioid required for the control of acute pain in psychoactive substance-using patients hospitalized in a trauma department. Material and methods: A descriptive, retrospective, and cross-sectional study was carried out by reviewing the records of patients with traumatic injury and a history of substance use who were treated under a multimodal analgesia scheme. Results: 75 patients with a mean age of 32 (± 9.6) years were included. The most frequently prescribed opioid was buprenorphine in 48% (mean dose 644 µg/24h), followed by morphine in 28% (mean dose 20 mg/24h) and tramadol in 24% of patients (mean dose 195 mg/24h). There was not statistically significant difference (p < 0.05) in pain control between the three groups, except that the intensity of pain in the morphine group was greater at 24 hours. Conclusion: The patients treated with buprenorphine had better pain control compared to the morphine group, although doses 40% higher than those recommended for trauma patients were required.


REFERENCES

  1. World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.8). Available in: https://wdr.unodc.org/wdr2019/prelaunch/WDR19_Booklet_1_EXECUTIVE_SUMMARY.pdf

  2. Villatoro-Velázquez JA, Reséndiz Escobar E, Mujica Salazar A, et al. Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017: Reporte de Drogas, 2017.

  3. CONADIC. Informe sobre la situación de la Salud Mental y el Consumo de Sustancias Psicoactivas en México. Observatorio Mexicano de Salud Mental y Consumo de Sustancias Psicoactivas. 2021.

  4. Cámara de diputados. Consumo excesivo de alcohol, principal causa de muerte y discapacidad; mata a más personas que el VIH/SIDA. Boletín N°. 5480. Disponible en: http://www5.diputados.gob.mx/index.php/esl/Comunicacion/Boletines/2018/Mayo/23/5480-Consumo-excesivo-de-alcohol-principal-causa-de-muerte-y-discapacidad-mata-a-mas-personas-que-el-VIH-SIDA

  5. Covarrubias-Gómez A, Betancourt-Sandoval JA, González-García JL. Adicciones, Anestesia y Dolor. Rev Mex Anest. 2011;34:200-210.

  6. Beaulieu P. Anesthetic implications of recreational drug use. Can J Anaesth. 2017;64:1236-1264. doi: 10.1007/s12630-017-0975-0.

  7. American Association of Nurse Anesthetist. Analgesia and anesthesia for substance use disorder patient. Available in: https://www.aana.com/docs/default-source/practice-aana-com-web-documents-(all)/analgesia-and-anesthesia-for-the-substance-use-disorderpatient.pdf?sfvrsn=3e6b7548_2

  8. Yang HT, Hur G, Kwak IS, et al. Improvement of burn pain management through routine pain monitoring and pain management protocol. Burns. 2013;39:619-624. doi: 10.1016/j.burns.2012.10.025.

  9. Ahmadi A, Bazargan-Hejazi S, Heidari Zadie Z, et al. Pain management in trauma: A review study. J Inj Violence Res. 2016;8:89?98. doi: 10.5249/jivr.v8i2.707.

  10. Serratos MC. Manejo del dolor en paciente con trauma. Rev Mex Anest. 2012;35:123-129.

  11. Khanna IK, Pillarisetti S. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res. 2015;8:859?870. doi: 10.2147/JPR.S85951.

  12. Bart G. Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 2012;31:207?225. doi: 10.1080/10550887.2012.694598.

  13. Acuña JP. Tratamiento del dolor agudo en el paciente dependiente de sustancias. Rev Med Clin Condes. 2014;25:664-673.

  14. Bates D, Schultheis BC, Hanes MC, et al. A Comprehensive Algorithm for Management of Neuropathic Pain. Pain Med. 2019;20:S2?S12. doi: 10.1093/pm/pnz075.

  15. Bravo L, Mico JA, Berrocoso E. Discovery and development of tramadol for the treatment of pain. Expert Opin Drug Discov. 2017;12:1281?1291. doi: 10.1080/17460441.2017.1377697.

  16. Vadivelu N, Singh-Gill H, Kodumudi G, et al. Practical guide to the management of acute and chronic pain in the presence of drug tolerance for the healthcare practitioner. Ochsner J. 2014;14:426?433.

  17. Vadivelu N, Lumermann L, Zhu R, et al. Pain Control in the Presence of Drug Addiction. Curr Pain Headache Rep. 2016;20:35. doi: 10.1007/s11916-016-0561-0.




2020     |     www.medigraphic.com